Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI-powered CCTA assessments show ‘close agreement’ with IVUS
Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound.
9 ways cardiovascular IT systems can improve your day-to-day workflow
Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.
Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio
Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.
CRT 2026: Key takeaways for interventional cardiologists
CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.
FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data
The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature.

FDA grants special recognition to AI software used to diagnose rare form of hypertension

The FDA has granted a breakthrough device designation for an artificial intelligence (AI) pattern recognition software being developed by Bayer and Merck & Co. in New Jersey that can identify signs of chronic thromboembolic pulmonary hypertension (CTEPH)—a rare form of hypertension—in CT pulmonary angiography (CTPA) scans, according to a Dec. 3 press release.

Images of atherosclerosis may boost patient adherence to CVD prevention

Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.

EMS response slower for cardiac arrest in low-income areas

It takes emergency medical services (EMS) almost four minutes longer to transport cardiac arrest patients from poor neighborhoods to the hospital versus those from high-income neighborhoods, according to a study of 2014 United States EMS data published in JAMA Network Open.

Arizona patients successfully receive the world’s first bioconvertible IVC filter commercially offered in US

BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.

Radiologist pinpoints where cardiac 3D imaging needs improvement

“We’d better make some rules because otherwise, you can have willy-nilly 3D printing...you can 3D print off your iPhone if you have the right hook-ups, right? But we don’t want that. We want to do really high-quality work," said Frank J. Rybicki, MD, PhD, at the American Heart Association’s 2018 Scientific Sessions in Chicago according to a report by Cardiovascular Business.

CT analysis before percutaneous PVI aids heart disease patients

Performing CT analysis prior to percutaneous pulmonary valve implantation (PPVI) in patients with congenital heart disease (CHD) may assist physicians in detecting those who are most at-risk for coronary artery compression during the operation.

CHD patients benefit from CT analysis prior to percutaneous PVI

CT analysis prior to percutaneous pulmonary valve implantation (PPVI) in patients with congenital heart disease (CHD) could help physicians detect which individuals are at the greatest risk for coronary artery compression during the procedure, according to research published ahead of print in the European Journal of Radiology.

FH patients without CAC safe from adverse events in short term

There were no adverse events related to atherosclerotic cardiovascular disease during a median 3.7 years of follow-up for 101 patients with familial hypercholesterolemia (FH) but a coronary artery calcium (CAC) score of zero, according to a study published Nov. 14 in JACC: Cardiovascular Imaging.

Cardiac Imaging

AI-powered CCTA assessments show ‘close agreement’ with IVUS

9 ways cardiovascular IT systems can improve your day-to-day workflow

Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio

CRT 2026: Key takeaways for interventional cardiologists

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data